S
Starling Oncology, Inc.
STLN · NASDAQ · Healthcare · 645M
Price · close
$6.46
-1.15% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-14.3×
Free cash flow yieldFCF yield
-5.2%
Return on equityROE
385.5%
Operating margin
-7.2%
Net debt / EBITDAbalance-sheet strength
-1.6×
Interest coverage
-3.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.